Growth Hormone Protocol
SM-130686Complete Dosing & Administration Guide
Experimental oral growth hormone secretagogue with anabolic potential from preclinical research
Dose Range
5-20mg
Frequency
Multiple times daily
Route
Oral capsule or powder
Cycle Length
8-12 weeks
Dosing
How much
do I take?
Timing
Best time to take
With meals (improves absorption and tolerability)
With food?
Recommended — take with breakfast, lunch, or dinner to enhance bioavailability
If stacking
Take consistently at same times daily. Morning and evening dosing supports natural GH pulse during sleep and wakefulness.
Adjusting Your Dose
Increase if
- +No side effects after 2 weeks
- +Desired GH stimulation not achieved (measure via IGF-1 if possible)
- +Body composition goals not met after 6-8 weeks at current dose
Decrease if
- -Appetite becomes excessive or uncomfortable
- -Joint pain or swelling develops
- -Sleep disturbances occur
- -Blood glucose fluctuations noticed (especially in diabetics)
Signs of right dose
- ✓Improved sense of well-being and energy
- ✓Gradual lean muscle gains (2-4 lbs per month)
- ✓Better recovery from training
- ✓Increased appetite without discomfort
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Administration
How do I
use it?
Reconstitution
What you need
- •Not applicable — oral formulation
Injection
Route
Not applicable — oral formulation only
Best sites
- •N/A
Technique
- 1.N/A
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
SM-130686 is a research compound that has never been tested in humans. All safety and efficacy data come from animal studies (primarily rats). No human clinical trials have been conducted. Use carries unknown risks. Potential side effects based on GH physiology and limited preclinical work.
PRECLINICAL ONLY — This compound has not entered human clinical trials. No FDA data available. Safety profile in humans is completely unknown. All dosing is extrapolated from rat studies and should not be considered established for human use. This is an experimental research compound.
Common Side Effects
Experienced by some users
Appetite stimulation
GHS-R agonists increase appetite through ghrelin-like action on hypothalamus. May be mild to moderate depending on dose and sensitivity.
Management: Eat planned meals to satisfy appetite. Stay hydrated. If excessive, reduce dose or frequency.
Transient water retention
GH promotes sodium retention and fluid shifts. Usually mild and resolves within days of stopping. Can slightly increase body weight independent of muscle gain.
Management: Maintain normal hydration and electrolyte intake. Reduction is natural when discontinuing. Monitor weight trends over 2-week intervals.
Less Common
- •Joint or muscle aches
- •Transient changes in blood glucose
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Severe or worsening joint pain (possible early carpal tunnel)
- ×Uncontrolled blood glucose elevation (especially if diabetic)
- ×Signs of edema or swelling in hands/feet that doesn't resolve
- ×Development of numbness or tingling in hands (median nerve compression)
- ×Severe sleep disturbances or mood changes
- ×Any signs of allergic reaction (rash, difficulty breathing, swelling)
- ×Diagnosis of cancer during treatment
- ×Symptoms suggestive of acromegaly progression (facial coarsening, hand/feet growth)
This is a research compound with no human safety data. Serious side effects are possible and unknown. If any concerning symptoms develop, discontinue immediately and seek medical evaluation. Unknown long-term effects. Do not combine with other GH secretagogues. This is NOT medical advice. Consult a physician before use.
Interactions
With other peptides
- !
- !
- !
- !
With medications
- !
- !
- !
- !
- !
With supplements
- ✓
- ✓
- ✓
- ✓
Want the Full Picture?
View the complete SM-130686 research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.
View Full SM-130686 Profile